![Samantha Truex](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 84 862 $ in data 30/04/2026
Samantha Truex is currently Chairman at Artios Pharma Ltd. since 2022 and Independent Director at Avalo Therapeutics, Inc. starting in 2024.
Former roles include Chief Executive Officer at Quench Bio, Inc. and Upstream Bio, Inc., Director at Sanofi from 1998 to 2006, Director at HotSpot Therapeutics, Inc., Vice President-Corporate Development at Biogen, Inc. from 2010 to 2014, Adviser at Atlas Venture Advisors, Inc., Chief Business Officer at Padlock Therapeutics, Inc., and Chief Operating Officer at Synlogic Therapeutics from 2016 to 2017.
Education includes an undergraduate degree from Dartmouth College in 1992, an undergraduate degree from Thayer School of Engineering at Dartmouth in 1993, and an MBA from Tuck School of Business at Dartmouth in 1995.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 28/03/2026 | 6.333 ( 0,02% ) | 84 862 $ | 30/04/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 28/03/2024 |
Artios Pharma Ltd.
 Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for cancer treatment | Presidente | 01/06/2022 |
| Società | Posizione | Fine |
|---|---|---|
Synlogic Therapeutics | Direttore operativo | 30/06/2017 |
| BIOGEN INC. | Direttore/Membro del Consiglio | 01/04/2010 |
| SANOFI | Direttore/Membro del Consiglio | 31/12/2006 |
| UPSTREAM BIO, INC. | Amministratore Delegato | - |
Atlas Venture Advisors, Inc.
 Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consulente / Consigliere | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 13 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Dartmouth College
 Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Tuck School of Business at Dartmouth
 Tuck School of Business at Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avalo Therapeutics, Inc.
 Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Thayer School of Engineering At Dartmouth
 Thayer School of Engineering At Dartmouth Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Padlock Therapeutics, Inc.
 Padlock Therapeutics, Inc. BiotechnologyHealth Technology Develops medicines targeting protein-arginine deiminases | Health Technology |
Artios Pharma Ltd.
Artios Pharma Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products for cancer treatment | Health Technology |
HotSpot Therapeutics, Inc.
 HotSpot Therapeutics, Inc. BiotechnologyHealth Technology Develops allosteric therapies | Health Technology |
Quench Bio, Inc.
 Quench Bio, Inc. BiotechnologyHealth Technology Develops therapies targeting innate immune pathways to treat life-threatening auto-immune and inflammatory diseases | Health Technology |
Synlogic Therapeutics | |
Upstream Bio, Inc.
 Upstream Bio, Inc. BiotechnologyHealth Technology Engages in developing treatments for inflammatory diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
MarketScreener is also available in this country: United States.
Switch edition
